TMCnet News
Global Pulmonary Arterial Hypertension Market to Grow 4.95% by 2021 - Key Players are Bayer AG, Gilead Sciences & Pfizer - Research and MarketsResearch and Markets has announced the addition of the "Global Pulmonary Arterial Hypertension (PAH) Market (By Drug Class, By Region, By Country): Opportunities and Forecasts (2016-2021)" report to their offering. The Global Pulmonary Arterial Hypertension market is projected to exhibit a CAGR of over 4.95% during 2016-2021. The report suggests that rising development of pipeline drugs in PAH combined with the growing awareness of the disease majorly in developed countries has resulted in the growth of PAH market. Also, the market for Pulmonary Arterial Hypertension (PAH) is growing moderately due to newer launches of pipeline drugs that target different pathways to suppress the symptoms of the disease. Early diagnosis of the disease has played a pivotal role in number of patients undergoing treatment. While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastruture and rising focus on healthcare among the growing middle class population. North America region remains the major market followed by Europe in the actual period. In the forecast period, APAC region will witness strong growth driven by countries such as India and China. Companies Mentioned:
Key Topics Covered: 1. Research Methodology 2. Executive Summary 3. Strategic Recommendations 4. Global PAH Market: An Overview 5. North America PAH Market: An Overview 6. Europe PAH Market: An Overview 7. APAC PAH Market: An Overview 8. Latin America PAH Market: An Overview 9. MEA PAH Market: An Overview 10. Market Dynamics 11. Policy and Regulatory Landscape 12. M&A and Licensing Route to the PAH Market 13. SWOT Analysis 14. Porter Five Force Model 15. Competitive Market Share Analysis 16. Competitive landscape 17. Company Profiles For more information about this report visit http://www.researchandmarkets.com/research/7xct6h/global_pulmonary Related Topics: Cardiovascular Drugs View source version on businesswire.com: http://www.businesswire.com/news/home/20160826005439/en/ |
